Prostacyclin and prostanoid modifiers aid ischemic skin flap survival

https://doi.org/10.1016/0022-4804(91)90233-CGet rights and content

Abstract

Prostacyclin, the stable prostacyclin analogue carbacyclin, the thromboxane synthetase inhibitor UK-38,485, and the phosphodiesterase inhibitor dipyridamole were tested on rabbit epigastric free flaps for their ability to improve flap survival after a period of ischemia. Control flaps infused with a balanced salt solution had a 39.9% survival, whereas prostacyclin, carbacyclin, and dipyridamole significantly increased flap survival to 68.4% (P < 0.05), 66.4% (P < 0.05), and 66.9% (P < 0.05), respectively. UK-38,485 improved survival slightly to 47.6% although not significantly. The improved flap survival correlated with the vasodilatory properties of the three successful agents whereas the antithrombotic properties of UK-38,485 were not sufficient, on their own, to increase flap survival.

References (34)

  • J.W. Hayhurst et al.

    An experimental study of microvascular technique, patency rates and related factors

    Brit. J. Plast. Surg.

    (1975)
  • P.C. Leung et al.

    The use of prostaglandins as local anti-thrombotic agents in microvascular surgery

    Brit. J. Plast. Surg.

    (1981)
  • D.J.M. Emerson et al.

    The use of prostacyclin in preventing occlusion of microvascular anastomoses by platelet thrombus: An experimental study in rats

    Brit. J. Plast. Surg.

    (1981)
  • K.R. Knight et al.

    Regulation of microvascular prostacyclin and thromboxane with inhibitors of arachidonic and metabolism

    Prostaglandins

    (1987)
  • J.W. May et al.

    The no-reflow phenomenon in experimental free flaps

    Plast. Reconstr. Surg.

    (1978)
  • A. Ames et al.

    Cerebral ischemia II. The no-reflow phenomenon

    Amer. J. Pathol.

    (1968)
  • M.F. Angel et al.

    The critical relationship between free radicals and degrees of ischemia: Evidence for tissue intolerance of marginal perfusion

    Plast. Reconstr. Surg.

    (1988)
  • Cited by (20)

    • Are prostaglandins or calcium channel blockers efficient for free flap salvage? A review of the literature

      2018, Journal of Stomatology, Oral and Maxillofacial Surgery
      Citation Excerpt :

      Knight et al. and Lepore et al. used the same model of epigastric free flap in rabbits. The free flaps were ex vivo stored at 25°C in saline-moistened gauze in a sealed sterile container for 21 hours and then revascularized by microvascular anastomoses to the contralateral side [9,10]. Knight et al. compared both in vivo systemic and local injection of physiologic serum in control group and prostaglandins after reperfusion.

    • In Vivo Observation of Leukocyte-Endothelium Interaction in Ischemia Reperfusion Injury With the Dorsal Window Chamber and the Effects of Pentoxifylline on Reperfusion Injury

      2007, Journal of Surgical Research
      Citation Excerpt :

      Different therapeutic agents have been recommended to improve survival of revascularised free flaps. Anticoagulants (heparin, hirudin, dextran), thrombolytic agents (streptokinase, urokinase), anti-inflammatory agents (aspirin, ibuprofen), free radical scavengers (superoxide dismutase, catalase, deferoxamine, allopurinol), and vasodilators (Ca channel blockers, dipyridamole, adenosine) have been used mostly experimentally [30–38]. Only a few have been used in clinical setting.

    • Iloprost and salvage of a free flap

      1996, British Journal of Plastic Surgery
    View all citing articles on Scopus
    View full text